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Available online 09 November 2016Background: The use of cardiac computed tomography (CT) in the evaluation of adult congenital heart disease pa-
tients is limited due to concerns of high radiation doses. The purpose of this study was to prospectively assess
whether low radiation dose cardiac CT is feasible to evaluate ventricular systolic function in adults with congen-
ital heart disease.
Methods: The study group included 30 consecutive patients with signiﬁcant congenital heart disease who
underwent a total of 35 ECG-gated cardiac CT scans utilizing a 320-detector row CT scanner. Each study included
a non-contrast scan and subsequent contrast-enhanced retrospectively-gated acquisition. Effective radiation
dose was estimated by multiplying the dose length product by a k-factor of 0.014 mSv/mGy cm.
Results: The mean age of the patients was 34.4 ± 8.9 years, 60% were men, and mean body mass index was
24.2 ± 4.3 kg/m2. A majority of patients (n = 28, 93.3%) had contraindications to cardiac MRI. A tube potential
of 80 kVwas used in 27 (77.1%) of the contrast-enhanced scans. The mean signal-to-noise and contrast-to-noise
ratios were 11.5 ± 3.9 and 10.3 ± 3.7, respectively. The median radiation dose for non-contrast and contrast-
enhanced images were 0.1 mSv (0.07–0.2 mSv) and 0.94 mSv (0.5–2.1 mSv), respectively. All 35 CT scans
were successfully analyzed for ventricular systolic function.
Conclusions:A low radiation contrast-enhanced, retrospectively-gated cardiac CTwith amedian radiation dose of
less than 1mSvwas successful in evaluating ventricular systolic function in 30 consecutive adult congenital heart
disease patients who underwent a total of 35 scans.
Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Adult congenital heart disease
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Radiation dose1. Introduction
With advancements in pediatric cardiac care, there is a growing pop-
ulation of adults with congenital heart disease [1–5]. Transthoracic
echocardiography is the ﬁrst-line modality for diagnosis and serial as-
sessment in congenital heart disease [6]. However, echocardiographic
assessment of cardiac function in adult congenital heart disease can be
challenging due to the complex anatomy, limited ﬁeld of view, and
poor echocardiographic windows following cardiac surgeries. Many ofeliability and freedom from bias
scular Imaging Laboratory,
rt, Lung, and Blood Institute,
, Room B1D416, Bethesda, MD
en access article under the CC BY-NCthese patients have a single ventricle or a morphologic right ventricle
that supports the systemic circulation. These ventricles deform under
the altered hemodynamics, and functional assessment is critical for clin-
ical care. The complex geometry of a single or right ventriclemake accu-
rate measurements of ventricular size and systolic function challenging
with echocardiography. Echocardiographic assessments of single or
right ventricular size and systolic function have meager reproducibility
in congenital heart disease patients [7–8]. Often, only qualitative assess-
ments of systolic function can be made, and volumetric imaging is re-
quired [9–10]. Cardiac magnetic resonance imaging (MRI) has been
used as a complementary or alternative technique due to the ability to
perform volumetric imagingwith no ionizing radiation [6,11–12]. How-
ever, cardiac MRI may be contraindicated in patients with pacemakers
or implantable cardioverter-deﬁbrillators.
The use of cardiac computed tomography (CT) in congenital heart
disease patients has been limited due to concerns over high radiation
dose and associated cancer risks [13–16]. Cardiac CT has been compared
favorably to MRI for ventricular volume and ejection fraction assess-
ments, even among patients with congenital heart disease [17–24].
We hypothesized that a low radiation dose contrast-enhanced,-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lar systolic function in adult congenital heart disease patients.
2. Methods
The institutional review board approved this prospective study. The
study protocol conformed to the ethical guidelines of the 1975 Declara-
tion of Helsinki. All of the subjects providedwritten informed consent to
participate. The study was registered on ClinicalTrials.gov (registration
NCT01621594). Inclusion criteria consisted of patients at least
18 years old with congenital heart disease who were clinically referred
for contrast-enhanced cardiac CT. Exclusion criteria were pregnancy or
renal dysfunction, estimated glomerular ﬁltration rate less than 30
mL/min/1.73 m2 [25]. Patients were not excluded for weight, heart
rate, or heart rhythm.
Overall, 30 consecutive patients underwent a total of 35 CT scans
with axial imaging using a second-generation, 320 × 0.5-mm detector
row CT unit (Aquilion ONE ViSION Edition; Toshiba Medical Systems,
Otawara, Japan) with a gantry rotation time of 275 msec. There were
5 patients with a second CT scan as part of a serial evaluation, not due
to an inadequate initial scan. Tube potential and tube current were de-
termined by automatic exposure control (SUREExposure3D, Toshiba
Medical Systems, SD 150 for non-contrast and SD 110 for contrast-
enhanced images) on the basis of the X-ray attenuation on scout images
and reconstruction kernel [26]. Images were reconstructed with a
512 × 512 matrix, 0.5 mm thick sections, and 0.25-mm increments
using kernel FC03, iterative reconstruction AIDR3D standard (Toshiba
Medical Systems) [27].
Patients were eligible to receive either metoprolol orally and/or in-
travenously to reduce the resting heart rate, though the majority did
not receive either (n = 27, 77.1%) due to being pacemaker-
dependent. An initial non-contrast scan was performed to delineate
prior surgical changes and determine the appropriate scan range for
the contrast-enhanced acquisition. Typically, Iopamidol (Isovue 370,
Bracco Diagnostics, Princeton, NJ; 370 mg of iodine per milliliter) was
injected via an antecubital vein at 5 mL/s in a triphasic protocol:
75 mL of contrast followed by 30 mL of a 50% contrast-50% saline mix-
ture and then 50 mL of saline. Breath-held retrospectively-gated
contrast-enhanced images were triggered within 1 s of a threshold of
600 Hounsﬁeld units in the left ventricular blood pool using bolus-
tracking. If an evaluation for coronary artery disease was requested, pa-
tients received 0.4 mg of sublingual nitroglycerin prior to imaging. Ef-
fective radiation doses were estimated by multiplying the dose-length
product (DLP) reported by the scanner by using a conversion factor of
0.014 mSv/mGy cm according to standard methodology [28]. Ventricu-
lar volumes and ejection fraction were quantiﬁed from 0.5 mm thickFig. 1. 46 year old (BMI 19.6) with congenitally corrected transposition of the great arteries,
windows. Four-chamber view demonstrating typical image quality at end-diastole and end-syslices using 5% phase increments on a workstation (Vital Images, Min-
netonka, MN). Fig. 1 shows an example of a contrast-enhanced CT
scan with end-diastolic and end-systolic frames. Cine videos from a
contrast-enhanced scan are available in the Supplementary material
(Videos 1–3). Data are presented as means ± standard deviations or
as median with interquartile range (IQR).
3. Results
In total, 30 patients with congenital heart disease underwent a total
of 35 scans from July 2013 to April 2016. Table 1 describes the baseline
characteristics of the patients, radiation doses, and image quality. The
primary diagnosis for the referred patients were classiﬁed as D-
transposition of the great arteries (n=7), atrial or ventricular septal de-
fect (n = 6), Tetralogy of Fallot (n = 5), double outlet right ventricle
(n = 5), congenitally corrected transposition of the great arteries
(n = 2), single ventricle (n = 2), congenital valve disease (n = 1),
Shone's complex (n = 1), or anomalous coronary artery (n = 1). The
patient's prior surgeries included atrial switch (n = 7), pulmonary
valve replacement (n = 6), ventricular septal defect repair (n = 6),
atrial septal defect repair (n = 5), transannular patch repair (n = 5),
double outlet right ventricle repair (2 ventricles, n = 5), lateral tunnel
Fontan (n = 2), prosthetic aortic valve replacement (n = 2), Ross pro-
cedure (n= 2), subaortic membrane resection (n= 1), mitral valve re-
pair (n = 1), and anomalous coronary artery reimplantation (n = 1).
The patients were primarily referred for cardiac CT to evaluate for ven-
tricular size and function but additional secondary evaluations in-
cluded: aortic size, main and branch pulmonary artery stenosis, bafﬂe
or Fontan obstructions, coronary artery anastomoses, and atheroscle-
rotic coronary artery disease. The vast majority of patients (n = 28,
93.3%) had contraindications to cardiacMRI due to pacemaker/implant-
able cardioverter-deﬁbrillator (n = 27) or breast tissue expander (n=
1). The remaining two patients were referred in part for coronary artery
disease evaluation.
The mean age was 34.4 ± 8.9 years (range 22–50 years) and 60%
(n = 18) were men. The mean body mass index (BMI) was 24.2 ±
4.3 kg/m2. Overall, 15 patients were overweight (n = 13, 43.3%) or
obese (n = 2, 6.7%). Only 8 patients (22.9%) received metoprolol, oral
or intravenous, prior to the CT scan. The mean heart rate during the
contrast-enhanced retrospectively-gated acquisition was 61.1 ±
6.6 bpm.
A tube potential of 80 kVwas used in 27 of the scans (77.1%)while a
tube potential of 100 kV was used in the remaining 8 scans (22.9%). On
the contrast-enhanced images, the mean signal-to-noise ratio (SNR)
and contrast-to-noise ratio (CNR) were 11.5 ± 3.9 and 10.3 ± 3.7, re-
spectively. The median radiation dose for non-contrast scans wascomplete heart block with dual chamber pacemaker and inadequate echocardiographic
stole with an effective radiation dose of 0.27 mSv.
Table 1
Patient characteristics, radiation dose estimates, and image quality.
All studies
(n = 35)
Mean age (years) 34.4 ± 8.9
Mean height (cm) 169.4 ± 9.4
Mean weight (kg) 70.2 ± 17
Mean body mass index (kg/m2) 24.2 ± 4.3
No of underweight patients (b18 kg/m2) 1 (3.3)
No of patients of normal weight (18–25 kg/m2) 14 (46.7)
No of overweight patients (25–30 kg/m2) 13 (43.3)
No of obese patients (30–40 kg/m2) 2 (6.7)
No of patients with contraindications to MRI 28 (93.3)
No of patients receiving oral beta-blockers before imaging 3 (8.6)
No of patients receiving intravenous beta-blockers before
imaging
7 (20)
Non-contrast CT median effective mAs 70 (45–115)
Non-contrast CT median DLPa (mGy cm) 7.2 (4.7–15.2)
Non-contrast CT median CTDIvolb (mGy) 0.6 (0.4–1.3)
Non-contrast CT median radiation dose (mSv) 0.1 (0.07–0.2)
Mean heart rate (bpm) during contrast-enhanced CT 61.1 ± 6.6
No of contrast-enhanced CT with 80 kV tube potential 27 (77.1%)
No of contrast-enhanced CT with 100 kV tube potential 8 (22.9%)
Contrast-enhanced CT median effective mAs 120 (90–200)
Contrast-enhanced CT median DLPa (mGy cm) 66.9
(39–147.8)
Contrast-enhanced CT median CTDIvolb (mGy) 5.1 (3.1–10.8)
Contrast-enhanced CT median radiation dose (mSv) 0.94 (0.5–2.1)
Contrast-enhanced CT mean signal-to-noise ratio 11.5 ± 3.9
Contrast-enhanced CT mean contrast-to-noise ratio 10.3 ± 3.7
a DLP-dose length product.
b CTDIvol-computed tomography dose index volume.
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enhanced scans was 0.94 mSv (0.5–2.1 mSv). For the 80 kV contrast-
enhanced scans, the median radiation dose was 0.74 mSv (0.49–
1.32 mSv). The radiation dose for the contrast-enhanced scans was
less than 1 mSv in 19 scans (54.2%) and less than 0.5 mSv in 7 scans
(20%). All scans were successfully analyzed for biventricular systolic
function where 2 ventricles were present.
4. Discussion
With decreasing mortality rates in children with congenital heart
disease, the number of adults with congenital heart disease is growing
and now outnumbers children [1–5]. Serial non-invasive imaging is
vital to clinical care as changes in ventricular volumes and systolic func-
tionmay necessitate repeat operation [29–31]. Echocardiography is the
clinical workhorse for non-invasive imaging in congenital heart disease
patients, however volumetric imaging may be required [6,9–10]. Car-
diac MRI is commonly utilized if transthoracic echocardiography is in-
adequate. However, adults with congenital heart disease may have
contraindications to MRI, particularly due to cardiac devices which are
increasingly required by this population prone to heart block, arrhyth-
mias, and sudden cardiac death [32].
Cardiac CT is a viable alternative for these patientswith a contraindi-
cation toMRI as there is excellent correlation in ventricular size and sys-
tolic function when compared to cardiac MRI in adults with congenital
heart disease [23–24]. Cardiac CT is unable to provide ﬂow quantiﬁca-
tion information that cardiacMRI canwith velocity encoded phase con-
trast imaging, but cardiac CT has clear advantages in spatial resolution
and fast acquisition time. CT is able to acquire volumetric coverage in
a single acquisition rather than the stepwise acquisition of multiple vol-
umes in cardiac MRI. Beyond assessment of ventricular size and func-
tion, cardiac CT allows for evaluation of the origins of coronary
arteries, atherosclerotic coronary artery disease, patency of conduits or
bafﬂes, posteroinferior rim in ostium secundum atrial septal defects,
and mediastinal adhesions prior to re-operation.
A clear concern when considering cardiac CT for serial evaluation is
the cumulative radiation dose [33]. A mean radiation dose of 7.6 mSvwas reported in an adult congenital heart disease population comparing
quantitative assessment of right ventricular volumes between 256-slice
CT and 3-Tesla MRI in 33 patients with surgically repaired Tetralogy of
Fallot [24]. A recent study reported a median radiation dose of approx-
imately 1.1 mSv for ventricular function analysis when using a tube po-
tential of 70 kV and tube current modulation [34]. However, the study
group did not represent consecutive patients undergoing cardiac CT.
In addition, 50% of the study population was less than 18 years of age
and manual adjustments were performed to lower the tube potential
if the recommended tube potential was higher than expected.
This studymarks another step forward in the use of cardiac CT in the
adult congenital heart disease population. The median radiation dose
for 35 consecutive contrast-enhanced CT scanswas less than 1mSv. No-
tably, this represented 30 consecutive patients as no patients were ex-
cluded due to body size, heart rate, or heart rhythm. The use of a
lower tube potential and a wide volume 320-detector row CT scanner
signiﬁcantly reduced the radiation dose for each scan [35]. There is the
potential to underestimate the effective radiation dose by using the
dose-length product and conversion factor of 0.014 mSv/mGy cm, but
this value is the current standard [28,35]. All scan parameters were
fully automated which could make wider implementation possible.
The use of a triphasic contrast protocol (contrast, contrast:saline mix,
saline) provided simultaneous opaciﬁcation of the right and left ventri-
cles (when present) to allow for the assessment of systolic function in
both ventricles. All scans were able to successfully analyze biventricular
systolic function where 2 ventricles were present.5. Limitations
Themain limitation of this study is the ventricular volumeswere not
validated against a reference standard such as cardiac MRI. However,
most patients (93.3%) had clear contraindications toMRI and all had in-
adequate 2D/3D echocardiographic windows. Despite the study
encompassing our experience over approximately 3 years, the total
sample size was small but still represented a spectrum of patients
with complex congenital heart disease. The current study utilized a
320-detector row CT scanner which is available in a limited number of
centers, but wewould advocate a similar approach using a low tube po-
tential if using a different CT scanner.6. Conclusions
A low radiation contrast-enhanced, retrospectively-gated cardiac CT
with a median radiation dose of less than 1 mSv was successful in eval-
uating ventricular systolic function in 30 consecutive adult congenital
heart disease patients who underwent a total of 35 scans.
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